← Back
Research Paper
Volume 15, Issue 24
pp 15473—15488
Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study
+
−
Reset
Figure 1.
Flow diagram of selecting patients.